Question 1

Which countries lead Hormonal and reproductive studies research?

Accepted Answer

By volume, the United States and China publish the most (1.2k and 615 works in 2022-now).

Question 2

Which institutions lead Hormonal and reproductive studies research?

Accepted Answer

By volume in 2022-now, Harvard University publishes the most Hormonal and reproductive studies research, followed by Baylor College of Medicine and University of Miami.

Question 3

Who are the leading researchers in Hormonal and reproductive studies?

Accepted Answer

The most-cited researchers publishing on Hormonal and reproductive studies include David Moher, George Davey Smith and Walter Churchill Willett.

Question 4

Where is Hormonal and reproductive studies research done?

Accepted Answer

The largest centres of Hormonal and reproductive studies research in 2022-now are Beijing (China), London (United Kingdom), São Paulo (Brazil) and New York (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Coral Gables and Florence.

Question 5

Where is the best place to study Hormonal and reproductive studies?

Accepted Answer

Among universities, judged by research, Harvard University, University of Copenhagen and University of Oslo score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

Question 6

Is Hormonal and reproductive studies research growing?

Accepted Answer

Output in 2022-2025 was 3% higher than in 2018-2021, peaking in 2024. The fastest-growing topics are Hormonal and reproductive studies.

Question 7

What are the most cited papers in Hormonal and reproductive studies?

Accepted Answer

The most cited paper in Hormonal and reproductive studies is "The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction" (Raymond C. Rosen, Alan J. Riley, Gorm Wagner et al., 1997), with 5,912 citations. Next come "Sexual Dysfunction in the United States" (5,146) and "Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis" (4,545).